Stock Market

Exact Sciences (NASDAQ:EXAS) reported results for the first quarter of 2023.

  • Exact Sciences reported a loss per share of 42 cents. That is much better than the analyst estimate for a loss of 75 cents per share.
  • The company reported revenue of $602.45 million.
  • This represents 10.8% positive surprise against the analyst estimate of $543.46 million.
  • You can read the full Exact Sciences press release here.

On the date of publication, Sarah Smith did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the Publishing Guidelines.

Sarah Smith is the Editor-in-Chief of

Articles You May Like

3 Stocks at the Cutting Edge of Blockchain Technology
AMD Stock: After AI Chip Debut, Should You Buy, Sell, or Hold?
Hollywood Shuffle: 2 Entertainment Stocks to Drop and 1 to Grab
3 Stocks Poised to Benefit from the Rise of Autonomous Delivery
3 Stocks Benefitting from the Global Electric Bike Boom